home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Genomics used in drugtesting

  November, 7 2001 0:31
your information resource in human molecular genetics
ChemGenex uses genomics approach to develop new anticancer drug and predict possible side effects

Understanding how genes respond to chemicals in diseased and normal tissues, in both cell cultures and living systems, can help researchers develop new drugs more efficiently. Such knowledge can spotlight drug toxicities, help select dosing regimens for clinical trials, and identify which patients may best benefit from treatment. Researchers from ChemGenex present data showing the use of chemical genomics and informatics in the development of a new cancer therapeutic, now in Phase I/II human testing.

ChemGenex Therapeutics

Joan Kureczka
J. Kureczka Associates

Message posted by: Wouter Kalle

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.